|
|
|
Country |
|
|
Company Name |
UNITED BIOTECH PRIVATE LIMITED |
Principal Name 1 |
Mr. Rajiv Kumar |
|
Status |
Satisfactory |
Principal Name 2 |
Mrs. Kavita Gakhar |
|
|
|
Registration # |
55-84814 |
|
Street Address |
E-142, Saket, |
||
|
Established Date |
31.01.1997 |
SIC Code |
-- |
|
Telephone# |
91-11-26855082/
40651100 |
Business Style 1 |
Manufacturer |
|
Fax # |
91-11-26855082/
66607096 |
Business Style 2 |
-- |
|
Homepage |
Product Name 1 |
Formulations |
|
|
# of employees |
-- |
Product Name 2 |
Injections |
|
Paid up capital |
Rs.
45,363,300/- |
Product Name 3 |
-- |
|
Shareholders |
Directors or relatives of directors 100.00% |
Banking |
Oriental Bank of Commerce |
|
Public Limited Corp. |
NO |
Business Period |
16 Years |
|
IPO |
NO |
International Ins. |
- |
|
Public |
NO |
Rating |
Ba (45) |
|
Related
Company |
|||
|
Relation
|
Country
|
Company
Name |
CEO |
|
Note |
- |
||
2. Summary
Financial Statement
|
Balance Sheet as of |
31.03.2011 |
(Unit: Indian Rs.) |
|
|
Assets |
Liabilities |
||
|
Current Assets |
1336,973,000 |
Current Liabilities |
105,648,000 |
|
Inventories |
218,535,000 |
Long-term Liabilities |
0,000 |
|
Fixed Assets |
444,144,000 |
Other Liabilities |
105,027,000 |
|
Deferred Assets |
0,000 |
Total Liabilities |
210,675,000 |
|
Invest& other Assets |
0,000 |
Retained Earnings |
1743,614,000 |
|
|
|
Net Worth |
1788,977,000 |
|
Total Assets |
1,999,652,000 |
Total Liab. & Equity |
1,999,652,000 |
|
Total Assets (Previous Year) |
1,473,291,000 |
|
|
|
P/L Statement as of |
31.03.2011 |
(Unit: Indian Rs.) |
|
|
Total Income |
1,266,664,000 |
Net Profit |
416,850,000 |
|
Total Income(Previous yr) |
1,003,349,000 |
Net Profit(Prev
yr) |
359,462,000 |
MIRA
INFORM REPORT
|
Report Date : |
06.05.2013 |
IDENTIFICATION DETAILS
|
Name : |
UNITED BIOTECH PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
E-142, Saket, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2011 |
|
|
|
|
Date of
Incorporation : |
31.01.1997 |
|
|
|
|
Com. Reg. No.: |
55-84814 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.45.363 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24239DL1997PTC084814 |
|
|
|
|
TAN No.: [Tax Deduction & Collection
Account No.] |
DELU02630F |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACU1839L |
|
|
|
|
Legal Form : |
Private Limited
Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer of
Pharmaceutical Products such as Formulations, Injections etc. |
|
|
|
|
No. of Employees
: |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (45) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 7100000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an
established company having a satisfactory track record. The financial for the
year 2012 are not available with the government department. As per previous
years, the performance of the company seems to be good. Trade relations
are reported to be fair. Business is active. Payments are reported to be
usually correct and as per commitment. The company can
be considered for normal business dealings at usual trade terms and
condition. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
LOCATIONS
|
Registered Office : |
E-142, Saket, |
|
Tel. No.: |
91-11-26855082/
40651100 |
|
Mobile No.: |
91-9810906070
(Mr. Sanjeev Kumar) |
|
Fax No.: |
91-11-26855082/
66607096 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
50000 sq ft |
|
Location : |
Owned |
|
|
|
|
Corporate Office : |
Plot – F,
C-Block, B-1 Mohan Co-operative Industrial Estate, |
|
Tel. No.: |
91-11-40651100/
66607095/ 66403098/ 99/ 26940762 |
|
Fax No.: |
91-11-66607096/
66607091 |
|
E mial: |
|
|
Location : |
Industrial |
|
|
|
|
Factory : |
Bagbania, Baddi, |
|
Te. No.: |
91-1795-236904/5/6 |
|
Fax No.: |
91-1795-236604 |
|
E-Mail : |
DIRECTORS
As on : 29.09.2011
|
Name : |
Mr. Rajiv Kumar |
|
Designation : |
Whole Time Director |
|
Address : |
E-142, Saket, |
|
Date of Birth/Age : |
09.04.1963 |
|
Qualification : |
Bachelor in Pharma |
|
Date of Appointment : |
31.01.1997 |
|
DIN No.: |
00073944 |
|
|
|
|
Name : |
Mrs. Kavita Gakhar |
|
Designation : |
Whole Time Director |
|
Address : |
E-142, Saket, |
|
Date of Birth/Age : |
11.10.1970 |
|
Qualification : |
MA |
|
Date of Appointment : |
01.08.2002 |
|
DIN No.: |
00073976 |
|
|
|
|
Name : |
Mrs. Kailash Devi Dhalu Ram Girdhar |
|
Designation : |
Whole Time Director |
|
Address : |
E-142, Saket, |
|
Date of Birth/Age : |
05.01.1937 |
|
Qualification : |
MA |
|
Date of Appointment : |
01.05.2002 |
|
DIN No.: |
00074289 |
|
|
|
|
Name : |
Mr. Sanjeev Kumar |
|
Designation : |
Whole-time Director |
|
Address : |
E-142, Saket Malviya Nagar, |
|
Date of Birth/Age : |
26.09.1966 |
|
Qualification : |
B. Pharma |
|
Date of Appointment : |
02.04.2007 |
|
DIN No.: |
01691559 |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on : 29.09.2011
|
Names of Shareholders |
No. of Shares |
|
Rajiv Kumar |
59233 |
|
Kailash Devi |
59233 |
|
Kavita Gakhar |
59234 |
|
Monica Gakhar |
29233 |
|
Ashwani Kumar |
59233 |
|
Sanjeev Kumar |
98233 |
|
Preeti Gakhar |
59234 |
|
Total
|
423633 |
Equity
Share Break up (Percentage of Total Equity)
As on : 29.09.2012
|
Category |
Percentage |
|
Directors or relatives of Directors |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of
Pharmaceutical Products such as formulations, injections etc. |
|
|
|
|
Products : |
SOL-U-PRED ·
Mucosys 20% ·
Noralian ·
Aminess-N ·
Umanalbumin 20% ·
Immunorho 300 ·
Isiven V.L. ·
Amphotin ·
Pipralin ·
Taxin NEW RANGE ·
Aprotec ·
Azom ·
Bioglandin ·
Dobutam ·
Follitec ·
Gavir ·
Menotec ·
Milron ·
Noxaparin ·
Otide ·
Streptonase ·
Tecoplan ·
T-pressin |
GENERAL INFORMATION
|
No. of Employees : |
Not Available |
|
|
|
|
Bankers : |
·
Oriental
Bank of Commerce, Hauz Khas Branch, ·
Standard
Chartered Bank ·
ICICI
Bank Limited ·
HDFC
Bank |
|
|
|
|
Facilities : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
VPGS and Company Chartered Accountant |
|
Address : |
3208, II Floor, |
|
Tel. No.: |
AAGFA7822G |
CAPITAL STRUCTURE
As on : 29.09.2012
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
500000 |
Equity Shares |
Rs. 100/-each |
Rs. 50.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
453633 |
Equity Shares |
Rs. 100/-each |
Rs. 45.363 Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
45.363 |
45.363 |
45.363 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
1743.614 |
1236.919 |
809.765 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
1788.977 |
1282.282 |
855.128 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
0.000 |
0.000 |
1.529 |
|
|
2] Unsecured Loans |
0.000 |
0.000 |
4.200 |
|
|
TOTAL BORROWING |
0.000 |
0.000 |
5.729 |
|
|
DEFERRED TAX LIABILITIES |
1.268 |
1.425 |
1.837 |
|
|
|
|
|
|
|
|
TOTAL |
1790.245 |
1283.707 |
862.694 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
444.144 |
441.043 |
459.201 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.000 |
0.000 |
0.000 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
218.535
|
187.193 |
174.717 |
|
|
Sundry Debtors |
185.510
|
200.319 |
163.893 |
|
|
Cash & Bank Balances |
812.299
|
430.636 |
97.138 |
|
|
Other Current Assets |
117.976
|
83.617 |
81.368 |
|
|
Loans & Advances |
221.188
|
130.262 |
35.601 |
|
Total
Current Assets |
1555.508
|
1032.027 |
552.717 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
0.000
|
0.000 |
50.764 |
|
|
Other Current Liabilities |
105.648
|
116.045 |
57.204 |
|
|
Provisions |
103.759
|
73.539 |
41.698 |
|
Total
Current Liabilities |
209.407
|
189.584 |
149.666 |
|
|
Net Current Assets |
1346.101
|
842.443 |
403.051 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.221 |
0.442 |
|
|
|
|
|
|
|
|
TOTAL |
1790.245 |
1283.707 |
862.694 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
|
|
|
|
|
|
Other Income |
|
|
|
|
|
|
TOTAL |
1266.664 |
1003.349 |
810.229 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Differed Revenue Expenditure Written off |
0.221 |
|
|
|
|
|
Other Expenditure |
721.731 |
543.973 |
|
|
|
|
TOTAL |
721.952 |
544.194 |
|
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION |
544.712 |
459.155 |
476.902 (Including
Depreciation ) |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
24.260 |
26.566 |
|
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX |
520.452 |
432.589 |
333.327 |
|
|
|
|
|
|
|
|
|
Less |
TAX |
103.602 |
73.127 |
42.05 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-I) |
416.850 |
359.462 |
291.277 |
|
|
|
|
|
|
|
|
|
Add |
TAX Paid U/S
115JB (MAT) Carried Forward |
89.845 |
67.692 |
0.000 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
1236.919 |
809.765 |
484.360 |
|
|
|
|
|
|
|
|
|
|
BALANCE CARRIED
TO THE B/S |
1743.614 |
1236.919 |
809.765 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
918.91 |
NA |
642.10 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
PAT / Total Income |
(%) |
32.90
|
35.82 |
35.95 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
26.02
|
29.37 |
32.94 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.29
|
0.34 |
0.39 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
0.00
|
0.00 |
0.00 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
7.43
|
5.44 |
3.69 |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
No |
|
9] |
Name of person contacted |
No |
|
10] |
Designation of contact
person |
No |
|
11] |
Turnover of firm for last
two years |
Yes |
|
12] |
Profitability for last
two years |
Yes |
|
13] |
Reasons for variation
<> 20% |
--------------------- |
|
14] |
Estimation for coming
financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister
concerns |
No |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
No |
|
20] |
Export / Import details
(if applicable) |
No |
|
21] |
Market information |
--------------------- |
|
22] |
Litigations that the firm
/ promoter involved in |
---------------------- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
No |
|
25] |
Conduct of the banking
account |
---------------------- |
|
26] |
Buyer visit details |
---------------------- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
Yes |
|
29] |
Last accounts filed at
ROC |
No |
|
30] |
Major Shareholders, if
available |
Yes |
|
31] |
Date of Birth of
Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of
Proprietor/Partner/Director, if available |
No |
|
33] |
Voter ID No of Proprietor/Partner/Director,
if available |
No |
|
34] |
External Agency Rating,
if available |
No |
BUSINESS
OPERATIONS :
This year had been marked as a year of outstanding commercial productions
of Baddi unit/ factory of the Company and the Company has performed well in
export market as well.
The members may note that the new Lyophilizer (Machinery used for
manufacturing Lyophilized Injections) acquired by the Company during the previous
year has already been installed and production has bee commenced
The Company is undertaking major expansion of plant and machinery in the
existing unit at Bagbania, Baddi-Nalagarh and expecting the completion of these
expansions within this financial year.
The export turnover of the Company has been tremendously increased by 10
times to Rs. 35.550 Millions against the previous years export turnover
amounting to Rs. 3.546 Millions. The major export markets are
The Company has already registered its products in
The Company started its own direct marketing operations in
The Company has already submitted the Dossiers for registering
products at
BANKERS CHARGES
REPORT AS PER REGISTRY :
|
Corporate
identity number of the company |
U24239DL1997PTC084814 |
|
Name of the
company |
UNITED BIOTECH PRIVATE LIMITED |
|
Address of the
registered office or of the principal place of business in |
E-142, Saket, |
|
This form is for |
Modification
of Charge |
|
Charge
identification (ID) number of the charge to be modified |
90337196 |
|
Type of charge |
·
Immovable
Property ·
Book
Debts ·
Floating
Charge ·
Others
(Stocks) |
|
Particular of
charge holder |
Oriental Bank of
Commerce, Hauz Khas institutional area, New Delhi-110016, Email : bm0562@obc.co.in |
|
Nature of
instrument creating charge |
Supplemental
Agreement to secure credit/ loan facilities |
|
Date of
instrument Creating the charge |
04.02.2013 |
|
Amount secured by
the charge |
Rs. 62.500
Millions |
|
Brief of the principal
terms an conditions and extent and operation of the charge |
Rate of Interest: Base Rate +3.50% Terms of Repayment: Payable on
demand. Margin: As per agreement Extend and Operation of the charge: 100% Others: The above is to secure
the credit facilities of Rs 62.500 Millions, granted by the Bank to the
company. |
|
Short particulars
of the property or asset(s) charged (including complete address and location
of the property) |
|
|
Date of Last
Modification |
13.05.2012 |
|
Particulars of
the present modification |
The various
credit facilities enhanced to Rs 62.500 Millions Other term and
condition remain the same |
FIXED ASSETS:
- Land
- Plant and Machinery
- Electrical Installation
- Furniture and Fixture
- Vehicles
- Computers
- Office Equipment
- Capital Work in Progress
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject:
None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 53.95 |
|
|
1 |
Rs. 83.81 |
|
Euro |
1 |
Rs. 70.50 |
INFORMATION DETAILS
|
Report Prepared
by : |
|
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
45 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NB |
NEW BUSINESS |
||
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.